| RYENX | VENAX | RYENX / VENAX | |
| Total Expense Ratio | 1.64 | 0.09 | 1,822% |
| Annual Report Gross Expense Ratio | 1.69 | 0.09 | 1,878% |
| Fund Existence | 22 years | 22 years | - |
| Gain YTD | 32.954 | 33.381 | 99% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.7M | 11.1B | 0% |
| Annual Yield % from dividends | 2.08 | 2.40 | 87% |
| Returns for 1 year | 41.40 | 37.20 | 111% |
| Returns for 3 years | 38.93 | 38.15 | 102% |
| Returns for 5 years | 142.59 | 143.49 | 99% |
| Returns for 10 years | 85.10 | 85.82 | 99% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AMGIX | 44.59 | 0.24 | +0.54% |
| American Century Disciplined Value I | |||
| FEQHX | 15.96 | 0.08 | +0.50% |
| Fidelity Hedged Equity | |||
| WSTCX | 104.35 | 0.27 | +0.26% |
| Nomura Science and Technology C | |||
| GEORX | 18.20 | 0.01 | +0.05% |
| Pear Tree Essex Environmental Opps R6 | |||
| CEIIX | 14.84 | -0.04 | -0.27% |
| Manning & Napier Callodine Equity Inc I | |||